U.S. Army Medical Department
USAMRIID Banner

About USAMRIID

Scientific Publications

Medical Library

Business Opportunities

Employment

Education & Training

Biosafety

Reference Materials

Related Links

Newsroom/Media

Contact Us

Search

>>  Home  >>  News Room


Feature Articles    Media



— News Releases —

— 2014 —

Novel Drug Treatment Protects Primates from Deadly Marburg Virus  (March 3, 2014)

— 2013 —

USAMRIID Scientist Wins Department of Defense’s Highest Civilian Honor  (November 18, 2013)

USAMRIID Deputy Commander to Receive 2013 Trailblazer Award at MD Women's Conference  (October 15, 2013)

USAMRIID Clinical Laboratory Passes CAP Accreditation Survey with Zero Deficiencies  (August 27, 2013)

Experimental Ebola Treatment Protects Some Primates Even After Disease Symptoms Appear  (August 21, 2013)

— 2012 —

Ebola Antibody Treatment, Produced in Plants, Protects Monkeys from Lethal Disease  (October 15, 2012)

Army Study:  DNA Vaccine and Duck Eggs Protect Against Hantavirus Disease  (May 23, 2012)

Army Scientist Nominated for 2012 Service to America Medal  (May 8, 2012)

Post-Exposure Antibody Treatment Protects Primates from Ebola, Marburg Viruses  (March 13, 2012)

Anthrax Capsule Vaccine Protects Monkeys from Lethal Infection  (January 12, 2012)

— 2011 —

Single Protein, Key to Ebola Virus Infection, Could Aid in Drug Design  (August 24, 2011)

USAMRIID Begins Clinical Trial of New Vaccine to Protect Against Ricin Toxin  (April 13, 2011)

— 2010 —

Novel "Antisense" Therapies Protect Primates from Lethal Ebola and Marburg Viruses   (August 22, 2010)

PDF file Overcoming Anthrax Bacterium's Natural Defenses Could Hold Key to New Treatment
  (May 18, 2010)

— 2009 —

Update on USAMRIID Scientist with Tularemia   (December 9, 2009)

USAMRIID Scientist Appears to be Ill with Tularemia   (December 4, 2009)

Single Host Gene May Hold Key to Treating Both Ebola and Anthrax Infections  (August 20, 2009)

— 2008 —

USAMRIID Scientist Leonard A. Smith Selected for Unique Leadership Position
  (June 19, 2008)

USAMRIID's Next Generation Anthrax Vaccine Acquired for Advanced Development
  (May 12, 2008)

Hopkins Biotech Program Enters Collaborative Relationship with USAMRIID  (May 9, 2008)

Scientists Determine Drug Target for the Most Potent Botulinum Neurotoxin  (April 29, 2008)

— 2007 —

USAMRIID Scientist Named to List of Ten Outstanding Young Americans  (September 20, 2007)

— 2006 —

Vaccine Combined with Short-Term Postexposure Antibiotics Protects Monkeys from
Inhalational Anthrax
  (May 1, 2006)

Experimental Vaccine Protects Nonhuman Primates When Given after Exposure to
Marburg Virus
  (April 26, 2006)

Environmental Impact Statement Planned for USAMRIID Facilities at Fort Detrick
  (February 8, 2006)

Gene-Specific Ebola Therapies Protect Nonhuman Primates from Lethal Disease
  (January 13, 2006)

— 2005 —

Anthrax Test, Developed by Army and CDC, Receives FDA Approval  (August 30, 2005)

Experimental Vaccine Protects Nonhuman Primates from Lassa Fever  (June 27, 2005)

Researchers Report Breakthrough Against World's Deadliest Viruses  (June 5, 2005)

Comprehensive Biodefense Text Published  (May 18, 2005)

— 2004 —

Vaccination with Anthrax Capsule Protects Against Experimental Infection in Animals  (December 1, 2004)

Research Team Develops Nonhuman Primate Model of Smallpox Infection  (October 5, 2004)

Managing Occupational Exposures to Potential Bioterrorist Agents  (August 20, 2004)

Protein Vaccine Fully Protects Mice from Lethal Aerosol Challenge with Ricin Toxin
  (August 4, 2004)

Fort Detrick Scientist Receives Bronze Star Medal for Iraq Service  (June 24, 2004)

Experimental Smallpox DNA Vaccine Protects Primates from Lethal Monkeypox  (April 27, 2004)

Experimental Smallpox Vaccine Protects against Monkeypox in Nonhuman Primates
  (March 10, 2004)

USAMRIID Scientist Peter B. Jahrling Elected Fellow by AAAS  (February 12, 2004)

Smallpox in 50-Year-Old Tissues Detected by Integrated Diagnostics Approach
  (January 29, 2004)

Small-Molecule Inhibitors of Anthrax Lethal Factor Identified  (January 22, 2004)

— 2003 —

Drug Shows Promise for Ebola Virus Treatment in Primates  (December 11, 2003)

Ebola Virus-Like Particles Protect Mice from Lethal Ebola Virus Infection  (December 9, 2003)

Small-Molecule Inhibitors of Botulinum Neurotoxin Identified  (November 12, 2003)

Experimental Hantavirus Vaccine Elicits Strong Antibody Response in Primates
  (October 23, 2003)

Documents on this page are PDF files .  In order to view these PDF documents, you must have Adobe Acrobat Reader installed on your computer.  If you already have this program, you may begin browsing the documents.  If you do not have this program, click on the link below to install it on your computer: http://get.adobe.com/reader.